nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.113	0.612	CbGbCtD
Rivastigmine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0718	0.389	CbGbCtD
Rivastigmine—Abnormal chest sounds NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0546	0.067	CcSEcCtD
Rivastigmine—Heart sounds abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0472	0.0579	CcSEcCtD
Rivastigmine—Breath sounds abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0205	0.0252	CcSEcCtD
Rivastigmine—Vestibular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0196	0.024	CcSEcCtD
Rivastigmine—Hallucination, visual—Cyclosporine—focal segmental glomerulosclerosis	0.0151	0.0185	CcSEcCtD
Rivastigmine—Tendon disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0151	0.0185	CcSEcCtD
Rivastigmine—Hyperkeratosis—Cyclosporine—focal segmental glomerulosclerosis	0.0138	0.0169	CcSEcCtD
Rivastigmine—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.013	0.016	CcSEcCtD
Rivastigmine—Carcinoma—Cyclosporine—focal segmental glomerulosclerosis	0.013	0.016	CcSEcCtD
Rivastigmine—Skin cancer—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0156	CcSEcCtD
Rivastigmine—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.011	0.0135	CcSEcCtD
Rivastigmine—Peripheral ischaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0132	CcSEcCtD
Rivastigmine—Paresis—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0132	CcSEcCtD
Rivastigmine—Stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0127	CcSEcCtD
Rivastigmine—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.00995	0.0122	CcSEcCtD
Rivastigmine—Stomach ache—Cyclosporine—focal segmental glomerulosclerosis	0.00926	0.0114	CcSEcCtD
Rivastigmine—Bacterial infection—Cyclosporine—focal segmental glomerulosclerosis	0.00852	0.0105	CcSEcCtD
Rivastigmine—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.00826	0.0101	CcSEcCtD
Rivastigmine—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.00814	0.00999	CcSEcCtD
Rivastigmine—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.00814	0.00999	CcSEcCtD
Rivastigmine—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00729	0.00894	CcSEcCtD
Rivastigmine—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.00693	0.0085	CcSEcCtD
Rivastigmine—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00677	0.0083	CcSEcCtD
Rivastigmine—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00677	0.0083	CcSEcCtD
Rivastigmine—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00677	0.0083	CcSEcCtD
Rivastigmine—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00669	0.00821	CcSEcCtD
Rivastigmine—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00647	0.00793	CcSEcCtD
Rivastigmine—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00607	0.00744	CcSEcCtD
Rivastigmine—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00607	0.00744	CcSEcCtD
Rivastigmine—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00589	0.00722	CcSEcCtD
Rivastigmine—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00556	0.00682	CcSEcCtD
Rivastigmine—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00551	0.00676	CcSEcCtD
Rivastigmine—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00546	0.0067	CcSEcCtD
Rivastigmine—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00522	0.00641	CcSEcCtD
Rivastigmine—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.0051	0.00625	CcSEcCtD
Rivastigmine—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00505	0.0062	CcSEcCtD
Rivastigmine—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00505	0.0062	CcSEcCtD
Rivastigmine—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00501	0.00615	CcSEcCtD
Rivastigmine—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00497	0.0061	CcSEcCtD
Rivastigmine—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.00486	0.00596	CcSEcCtD
Rivastigmine—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.00482	0.00591	CcSEcCtD
Rivastigmine—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00461	0.00565	CcSEcCtD
Rivastigmine—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00454	0.00557	CcSEcCtD
Rivastigmine—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00451	0.00553	CcSEcCtD
Rivastigmine—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00448	0.00549	CcSEcCtD
Rivastigmine—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00439	0.00538	CcSEcCtD
Rivastigmine—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00436	0.00534	CcSEcCtD
Rivastigmine—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00436	0.00534	CcSEcCtD
Rivastigmine—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00433	0.00531	CcSEcCtD
Rivastigmine—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00433	0.00531	CcSEcCtD
Rivastigmine—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00427	0.00524	CcSEcCtD
Rivastigmine—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00427	0.00524	CcSEcCtD
Rivastigmine—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00424	0.0052	CcSEcCtD
Rivastigmine—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00421	0.00517	CcSEcCtD
Rivastigmine—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00413	0.00507	CcSEcCtD
Rivastigmine—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00393	0.00483	CcSEcCtD
Rivastigmine—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00387	0.00474	CcSEcCtD
Rivastigmine—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00382	0.00469	CcSEcCtD
Rivastigmine—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0038	0.00466	CcSEcCtD
Rivastigmine—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.0038	0.00466	CcSEcCtD
Rivastigmine—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00376	0.00461	CcSEcCtD
Rivastigmine—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00374	0.00458	CcSEcCtD
Rivastigmine—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00369	0.00453	CcSEcCtD
Rivastigmine—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.00443	CcSEcCtD
Rivastigmine—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.0036	0.00441	CcSEcCtD
Rivastigmine—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.0036	0.00441	CcSEcCtD
Rivastigmine—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.00436	CcSEcCtD
Rivastigmine—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.00436	CcSEcCtD
Rivastigmine—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00343	0.00421	CcSEcCtD
Rivastigmine—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00341	0.00419	CcSEcCtD
Rivastigmine—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00341	0.00419	CcSEcCtD
Rivastigmine—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00335	0.00411	CcSEcCtD
Rivastigmine—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00328	0.00403	CcSEcCtD
Rivastigmine—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00325	0.00399	CcSEcCtD
Rivastigmine—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.00395	CcSEcCtD
Rivastigmine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.00392	CcSEcCtD
Rivastigmine—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.00392	CcSEcCtD
Rivastigmine—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.0039	CcSEcCtD
Rivastigmine—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00316	0.00388	CcSEcCtD
Rivastigmine—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00311	0.00381	CcSEcCtD
Rivastigmine—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.00378	CcSEcCtD
Rivastigmine—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00305	0.00375	CcSEcCtD
Rivastigmine—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00304	0.00373	CcSEcCtD
Rivastigmine—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00303	0.00371	CcSEcCtD
Rivastigmine—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.00368	CcSEcCtD
Rivastigmine—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.00367	CcSEcCtD
Rivastigmine—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00363	CcSEcCtD
Rivastigmine—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00294	0.0036	CcSEcCtD
Rivastigmine—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.00359	CcSEcCtD
Rivastigmine—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.00359	CcSEcCtD
Rivastigmine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00286	0.0035	CcSEcCtD
Rivastigmine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.00348	CcSEcCtD
Rivastigmine—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00345	CcSEcCtD
Rivastigmine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00345	CcSEcCtD
Rivastigmine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.00332	CcSEcCtD
Rivastigmine—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.00321	CcSEcCtD
Rivastigmine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.0032	CcSEcCtD
Rivastigmine—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.00317	CcSEcCtD
Rivastigmine—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.00315	CcSEcCtD
Rivastigmine—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.0031	CcSEcCtD
Rivastigmine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00309	CcSEcCtD
Rivastigmine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00303	CcSEcCtD
Rivastigmine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.00298	CcSEcCtD
Rivastigmine—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.00297	CcSEcCtD
Rivastigmine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.0024	0.00295	CcSEcCtD
Rivastigmine—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00237	0.00291	CcSEcCtD
Rivastigmine—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.00283	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00281	CcSEcCtD
Rivastigmine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.0028	CcSEcCtD
Rivastigmine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00276	CcSEcCtD
Rivastigmine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00274	CcSEcCtD
Rivastigmine—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00273	CcSEcCtD
Rivastigmine—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00272	CcSEcCtD
Rivastigmine—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.0027	CcSEcCtD
Rivastigmine—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.0027	CcSEcCtD
Rivastigmine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.00269	CcSEcCtD
Rivastigmine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00266	CcSEcCtD
Rivastigmine—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00265	CcSEcCtD
Rivastigmine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00265	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00265	CcSEcCtD
Rivastigmine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00214	0.00262	CcSEcCtD
Rivastigmine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00214	0.00262	CcSEcCtD
Rivastigmine—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00257	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00255	CcSEcCtD
Rivastigmine—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00255	CcSEcCtD
Rivastigmine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.00253	CcSEcCtD
Rivastigmine—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00244	CcSEcCtD
Rivastigmine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00243	CcSEcCtD
Rivastigmine—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00242	CcSEcCtD
Rivastigmine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00242	CcSEcCtD
Rivastigmine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00241	CcSEcCtD
Rivastigmine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.00241	CcSEcCtD
Rivastigmine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00239	CcSEcCtD
Rivastigmine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00238	CcSEcCtD
Rivastigmine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00238	CcSEcCtD
Rivastigmine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00234	CcSEcCtD
Rivastigmine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00226	CcSEcCtD
Rivastigmine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00225	CcSEcCtD
Rivastigmine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.0022	CcSEcCtD
Rivastigmine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.00218	CcSEcCtD
Rivastigmine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00217	CcSEcCtD
Rivastigmine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00217	CcSEcCtD
Rivastigmine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.00214	CcSEcCtD
Rivastigmine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.00212	CcSEcCtD
Rivastigmine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00211	CcSEcCtD
Rivastigmine—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00208	CcSEcCtD
Rivastigmine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00207	CcSEcCtD
Rivastigmine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00207	CcSEcCtD
Rivastigmine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00205	CcSEcCtD
Rivastigmine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00203	CcSEcCtD
Rivastigmine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00199	CcSEcCtD
Rivastigmine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00198	CcSEcCtD
Rivastigmine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00196	CcSEcCtD
Rivastigmine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00195	CcSEcCtD
Rivastigmine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00194	CcSEcCtD
Rivastigmine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.0019	CcSEcCtD
Rivastigmine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.0019	CcSEcCtD
Rivastigmine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00184	CcSEcCtD
Rivastigmine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00183	CcSEcCtD
Rivastigmine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00182	CcSEcCtD
Rivastigmine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.0018	CcSEcCtD
Rivastigmine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.0018	CcSEcCtD
Rivastigmine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.0018	CcSEcCtD
Rivastigmine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00179	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00178	CcSEcCtD
Rivastigmine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00177	CcSEcCtD
Rivastigmine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00176	CcSEcCtD
Rivastigmine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00174	CcSEcCtD
Rivastigmine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00172	CcSEcCtD
Rivastigmine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00171	CcSEcCtD
Rivastigmine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00169	CcSEcCtD
Rivastigmine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00169	CcSEcCtD
Rivastigmine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00167	CcSEcCtD
Rivastigmine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00166	CcSEcCtD
Rivastigmine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00164	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00157	CcSEcCtD
Rivastigmine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00156	CcSEcCtD
Rivastigmine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00155	CcSEcCtD
Rivastigmine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00154	CcSEcCtD
Rivastigmine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00153	CcSEcCtD
Rivastigmine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00152	CcSEcCtD
Rivastigmine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.0015	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00149	CcSEcCtD
Rivastigmine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00148	CcSEcCtD
Rivastigmine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00147	CcSEcCtD
Rivastigmine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00147	CcSEcCtD
Rivastigmine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00142	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00141	CcSEcCtD
Rivastigmine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00137	CcSEcCtD
Rivastigmine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00136	CcSEcCtD
Rivastigmine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00136	CcSEcCtD
Rivastigmine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00127	CcSEcCtD
Rivastigmine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00124	CcSEcCtD
Rivastigmine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000993	0.00122	CcSEcCtD
Rivastigmine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00096	0.00118	CcSEcCtD
Rivastigmine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000928	0.00114	CcSEcCtD
Rivastigmine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000892	0.00109	CcSEcCtD
Rivastigmine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000885	0.00109	CcSEcCtD
Rivastigmine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000884	0.00108	CcSEcCtD
Rivastigmine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000879	0.00108	CcSEcCtD
Rivastigmine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000834	0.00102	CcSEcCtD
